|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2001)) |
IUPAC Name ![]() |
| dimethyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7463 | almotriptan |
Synonyms ![]() |
| Axert® |
| LAS-31416 |
| PNU-180638E |
Database Links ![]() |
|
| CAS Registry No. | 154323-57-6 |
| ChEMBL Ligand | CHEMBL1505 |
| DrugBank Ligand | DB00918 |
| PubChem CID | 123606 |
| Search Google for chemical match using the InChIKey | WKEMJKQOLOHJLZ-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | WKEMJKQOLOHJLZ |
| Search PubMed clinical trials | almotriptan |
| Search PubMed titles | almotriptan |
| Search PubMed titles/abstracts | almotriptan |
| Wikipedia | almotriptan |
| Comments |
| Almotriptan is a triptan (tryptamine-based) drug. It is used to treat migraines headaches but does not prevent or cure them. |